Toggle menu
Toggle preferences menu
Toggle personal menu
Not logged in
Your IP address will be publicly visible if you make any edits.

Morphine: Difference between revisions

From Pharmacopedia
[unchecked revision][checked revision]
Expand stub to full MedTemplate parameter set
parser-claude: Morphine MedTemplate refill, Top 300 stub upgrade
 
(7 intermediate revisions by 3 users not shown)
Line 1: Line 1:
{{MedTemplate
{{MedTemplate
| generic           = Morphine
| generic           = Morphine (sulfate)
| brand             =  
| brand             = MS Contin (ER), Kadian (ER), Avinza (ER), Roxanol (IR oral solution), Duramorph (epidural / IT), Astramorph (IV), Infumorph (intrathecal pump), MorphaBond (IR abuse-deterrent)
| structure         =  
| structure         =
| classes           = Opioid, Analgesic
| classes           = [[:Category:Opioid analgesics|Opioid analgesic (natural phenanthrene from opium poppy)]], [[:Category:Schedule II controlled substances|Schedule II controlled substance]], [[:Category:Analgesics|Analgesic]]
| mechanism          = Mu-opioid receptor agonist
| uses              = <vote slug="moderate-severe-acute-pain-use">Moderate to severe acute pain (FDA)</vote>, <vote slug="severe-chronic-pain-use">Severe chronic pain unresponsive to non-opioid alternatives (FDA, with CDC opioid prescribing guidance constraints)</vote>, <vote slug="cancer-pain-use">Cancer pain (FDA; the global gold standard, WHO essential medicine)</vote>, <vote slug="preoperative-analgesia-use">Preoperative analgesia (FDA)</vote>, <vote slug="epidural-intrathecal-pain-use">Epidural and intrathecal pain management (FDA)</vote>
| uses              =  
| starting_dose     = IR oral: 15-30 mg every 4 hours as needed. ER opioid-naive: 15-30 mg every 12 hours. IV/IM/SC: 2-10 mg every 3-4 hours. Epidural / intrathecal: see surgical or palliative-care protocols
| starting_dose     =  
| preparations     = IR tablets 15, 30 mg; oral solution 10 mg/5 mL, 20 mg/mL, 100 mg/5 mL (concentrated); suppositories; ER tablets and capsules in multiple strengths; injectable 0.5-50 mg/mL
| preparations       =  
| fda_max          = No fixed ceiling; titrate to clinical effect and tolerability with CDC opioid prescribing guidance constraints on morphine-milligram-equivalent (MME) totals
| routes            =
| pill_id           =
| onset              =  
| routes            = Oral, intravenous, intramuscular, subcutaneous, epidural, intrathecal, rectal
| duration           =  
| onset            = 5-10 minutes (IV); 30 minutes (oral IR); slower for ER and rectal
| halflife          =  
| duration         = 3-5 hours (IR); 8-24 hours (ER); 12-24 hours (epidural / intrathecal)
| bioavailability    =  
| halflife          = Morphine 2-4 hours; morphine-6-glucuronide active metabolite 2-4 hours (longer with renal impairment)<ref name="mscontin-label">FDA Prescribing Information, MS Contin (morphine sulfate extended-release), Purdue/Mallinckrodt, current revision. https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/019516s058lbl.pdf</ref>
| pregnancy         =  
| bioavailability   = ~25-40% (oral; extensive first-pass)<ref name="mscontin-label" />
| legal              =  
| pregnancy        = Chronic third-trimester exposure produces neonatal opioid withdrawal syndrome and respiratory depression at delivery.{{citation needed}}
| intro              =  
| legal             = [[USLegal:Schedule II|Schedule II controlled substance]] in US; WHO essential medicine<ref name="mscontin-label" />
| pharmacokinetics   =  
| mechanism         = <vote slug="morphine-mech-claim">'''Prototype μ-opioid receptor agonist''', the natural reference compound from which all other opioid analgesics are characterized by relative potency. Metabolized predominantly by UGT2B7 glucuronidation to morphine-3-glucuronide (M3G, inactive at μ but possibly neuroexcitatory at high concentrations) and morphine-6-glucuronide (M6G, active μ agonist, more potent than parent morphine and renally eliminated, so accumulates in renal impairment to produce prolonged respiratory depression).</vote> Histamine release with IV bolus produces flushing and hypotension. Crucially, morphine is '''not''' CYP2D6-dependent (no metabolic activation step is needed, unlike codeine and hydrocodone), so analgesic efficacy is genotype-independent. The Schedule II status and the CDC opioid prescribing guidance shape current clinical use<ref name="mscontin-label" />.
| pharmacodynamics  =  
| indications        =  
| dosing             =  
| effects            =  
| contraindications  =
| interactions      =
| pregnancy_details  =
| monitoring         =  
| counseling        =  
| anecdotes          =
| seealso            =
| references        =  
}}
}}


{{PendellsCorner
| quote  = Opium is the archetypal medicine, and morphine is its essence. Morphine is the most powerful naturally occurring analgesic in the world, and the synthetics use opium as their precursor.
| volume = Poeia
| page  = 123
}}
== References ==
<references />
[[Category:Opioid analgesics]]
[[Category:Schedule II controlled substances]]
[[Category:Analgesics]]
[[Category:Analgesics]]
 
[[Category:Natural opioids]]